Several members of m6A writer complexes and readers exhibited 1% mutation frequency, while main methyltransferases (METTL3, METTL14) and demethylases (FTO, ALKHB5) did not mutate in breast cancer samples (Figure 1A). This evidence concerns the gene MBD2 and breast carcinoma.